User profiles for Jose U. Scher

Jose U. Scher

Steere Abramson Associate Professor of Medicine and Rheumatology, NYU School of …
Verified email at nyumc.org
Cited by 11660

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

JU Scher, A Sczesnak, RS Longman, N Segata… - elife, 2013 - elifesciences.org
10.7554/eLife.01202.001 Rheumatoid arthritis (RA) is a prevalent systemic autoimmune
disease, caused by a combination of genetic and environmental factors. Animal models suggest …

Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease

JU Scher, C Ubeda, A Artacho, M Attur… - Arthritis & …, 2015 - Wiley Online Library
… Littman, MD, PhD: Kimmel Center for Biology and Medicine of the Skirball Institute and New
York University, New York, New York. Drs. Scher and Ubeda contributed equally to this work…

[HTML][HTML] Covid-19 in immune-mediated inflammatory diseases—case series from New York

…, S Adhikari, D Hudesman, JU Scher - … England Journal of …, 2020 - Mass Medical Soc
Covid-19 in Immune-Mediated Inflammatory Diseases The authors describe patients in New
York City with known immune-mediated inflammatory disease in whom Covid-19 developed …

2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis

…, AM Orbai, SM Reddy, JU Scher… - Journal of Psoriasis …, 2019 - journals.sagepub.com
Objective: To develop an evidence-based guideline for the pharmacologic and nonpharmacologic
treatment of psoriatic arthritis (PsA), as a collaboration between the American College …

Periodontal disease and the oral microbiota in new‐onset rheumatoid arthritis

JU Scher, C Ubeda, M Equinda, R Khanin… - Arthritis & …, 2012 - Wiley Online Library
Objective To profile the abundance and diversity of subgingival oral microbiota in patients
with never‐treated, new‐onset rheumatoid arthritis (RA). Methods Periodontal disease (PD) …

The role of the gut microbiome in systemic inflammatory disease

JC Clemente, J Manasson, JU Scher - Bmj, 2018 - bmj.com
The role of the gut microbiome in models of inflammatory and autoimmune disease is now
well characterized. Renewed interest in the human microbiome and its metabolites, as well as …

The microbiome and rheumatoid arthritis

JU Scher, SB Abramson - Nature reviews rheumatology, 2011 - nature.com
Humans are not (and have never been) alone. From the moment we are born, millions of
micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our …

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

…, G Schett, MJ Mulligan, JU Scher - Annals of the …, 2021 - ard.bmj.com
Objective To investigate the humoral and cellular immune response to messenger RNA (mRNA)
COVID-19 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) …

15d-PGJ2: the anti-inflammatory prostaglandin?

JU Scher, MH Pillinger - Clinical immunology, 2005 - Elsevier
15-Deoxy-Δ- 12,14 -prostaglandin J 2 (15d-PGJ 2 ) is the most recently discovered
prostaglandin. This cyclopentanone, the dehydration end product of PGD 2 , differs from other …

The anti-inflammatory effects of prostaglandins

JU Scher, MH Pillinger - Journal of Investigative Medicine, 2009 - journals.sagepub.com
Long regarded as proinflammatory molecules, prostaglandins (PGs) also have anti-inflammatory
effects. Both prostaglandin D 2 (PGD 2 ) and its dehydration end product 15-deoxy-Δ 12…